Evidence mapPaperPMID 42238698Full record

ArticleFrontiers in chemistry2026

QSPR analysis of the drugs used to treat major depressive disorder using degree and neighborhood degree based indices.

J J Jeni Godlin, S Radha

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

J J Jeni GodlinSchool of Advanced Sciences, Vellore Institute of Technology, Chennai, India.
S RadhaSchool of Advanced Sciences, Vellore Institute of Technology, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The high risk of suicide among major depressive disorder (MDD) patients, together with its substantial contribution to the global burden of disease, emphasizes the necessity of effective drug evaluation strategies. However, traditional clinical trials for MDD drugs are costly and time-consuming, emphasizing the importance of computational approaches such as QSPR modeling for predicting drug behavior and physicochemical properties. Methods: This study employs degree- and neighborhood degree-based topological indices to characterize the molecular structures of MDD drugs. Topological indices were calculated and analyzed against the physicochemical properties of the drugs using linear, quadratic, and logarithmic regression models to identify the most suitable predictive models, followed by validation to assess their robustness and predictive reliability. Results: Degree- and neighborhood degree-based topological indices exhibited strong correlations with the physicochemical properties of MDD drugs. Among the linear, quadratic, and logarithmic regression analyses performed, the most suitable predictive models were identified, and model validation confirmed their robustness and predictive reliability. Discussion: The strong correlations observed between degree- and neighborhood degree-based topological indices and the physicochemical properties of MDD drugs demonstrate the effectiveness of graph-theoretical descriptors in QSPR modeling. The validated predictive models demonstrate the potential of computational approaches to support efficient drug evaluation and rational drug design, reducing reliance on costly and time-consuming experimental studies.

Indexed as

degree-based indicesedge partitionsmajor depressive disorder drugsneighborhood degree-based indicesQSPRregression analysis

Identifiers

PMID42238698
PMCPMC13226495

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.